Indevus Plans To Relaunch Valstar By Year-End

Company announces submission of an sNDA for bladder cancer treatment, which was pulled from the market in 2002 due to manufacturing issues.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet